Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Martinelli

Showing results (171-180 of 191) with videos related to

Pageof 20
Sort By:
ESMO Gastrointestinal Oncology|March 27, 2026
Effectiveness of FTD/TPI plus bevacizumab and impact of prior bevacizumab exposure in patients with mCRC: the Italian FLOWER studyG Trovato, M Carullo, A Nicastro, et al.
The Journal of Clinical Endocrinology and Metabolism|April 10, 2014
Sonic hedgehog signaling is active in human adrenal cortex development and deregulated in adrenocortical tumorsDébora C Gomes, Letícia F Leal, Livia M Mermejo, et al.
Oncotarget|October 6, 2016
Unraveling the expression of the oncogene YAP1, a Wnt/beta-catenin target, in adrenocortical tumors and its association with poor outcome in pediatric patientsRafael H Abduch, Ana Carolina Bueno, Leticia F Leal, et al.
ESMO Open|December 3, 2025
Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trialE Elez, S Siena, A Sartore-Bianchi, et al.
ESMO Open|January 5, 2023
Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II studyC Cardone, A De Stefano, G Rosati, et al.
Journal of Endocrinological Investigation|March 23, 2011
Effects of depot growth hormone replacement on thyroid function and volume in adults with congenital isolated growth hormone deficiencyN T F Leite, R Salvatori, M R S Alcântara, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2021
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancerT Yoshino, G Argilés, E Oki, et al.
Arquivos Brasileiros De Endocrinologia E Metabologia|January 11, 2005
[Growth or somatotrophic hormone: new perspectives in isolated GH deficiency after description of the mutation in the GHRH receptor gene in individuals of Itabaianinha County, Brazil]Anita Hermínia O Souza, Roberto Salvatori, Carlos E Martinelli, et al.
ESMO Open|April 29, 2023
Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancerG Martini, V Belli, S Napolitano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2018
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOSK Muro, F Lordick, T Tsushima, et al.
Pageof 20

Showing results (171-180 of 191) with videos related to

Sort By:
Pageof 20
ESMO Gastrointestinal Oncology|March 27, 2026
Effectiveness of FTD/TPI plus bevacizumab and impact of prior bevacizumab exposure in patients with mCRC: the Italian FLOWER studyG Trovato, M Carullo, A Nicastro, et al.
The Journal of Clinical Endocrinology and Metabolism|April 10, 2014
Sonic hedgehog signaling is active in human adrenal cortex development and deregulated in adrenocortical tumorsDébora C Gomes, Letícia F Leal, Livia M Mermejo, et al.
Oncotarget|October 6, 2016
Unraveling the expression of the oncogene YAP1, a Wnt/beta-catenin target, in adrenocortical tumors and its association with poor outcome in pediatric patientsRafael H Abduch, Ana Carolina Bueno, Leticia F Leal, et al.
ESMO Open|December 3, 2025
Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trialE Elez, S Siena, A Sartore-Bianchi, et al.
ESMO Open|January 5, 2023
Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II studyC Cardone, A De Stefano, G Rosati, et al.
Journal of Endocrinological Investigation|March 23, 2011
Effects of depot growth hormone replacement on thyroid function and volume in adults with congenital isolated growth hormone deficiencyN T F Leite, R Salvatori, M R S Alcântara, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2021
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancerT Yoshino, G Argilés, E Oki, et al.
Arquivos Brasileiros De Endocrinologia E Metabologia|January 11, 2005
[Growth or somatotrophic hormone: new perspectives in isolated GH deficiency after description of the mutation in the GHRH receptor gene in individuals of Itabaianinha County, Brazil]Anita Hermínia O Souza, Roberto Salvatori, Carlos E Martinelli, et al.
ESMO Open|April 29, 2023
Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancerG Martini, V Belli, S Napolitano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2018
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOSK Muro, F Lordick, T Tsushima, et al.
Pageof 20